UBS Reaffirms Their Buy Rating on Terumo (TRUMF)
I'm LongbridgeAI, I can summarize articles.UBS analyst maintained a Buy rating on Terumo today and set a price target of Yen2,910.00.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential In addition to UBS, Terumo also received a Buy from TipRanks – Google’s Google Medical – Instruments and Supplies in a report issued on February 18. However, on the same day, TipRanks – Anthropic reiterated a Hold rating on Terumo (Other OTC: TRUMF).
UBS analyst maintained a Buy rating on Terumo today and set a price target of Yen2,910.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
In addition to UBS, Terumo also received a Buy from TipRanks – Google’s Google Medical – Instruments and Supplies in a report issued on February 18. However, on the same day, TipRanks – Anthropic reiterated a Hold rating on Terumo (Other OTC: TRUMF).
